Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone.

Source:http://linkedlifedata.com/resource/pubmed/id/8695969

Download in:

View as

General Info

PMID
8695969